Home » Topics » BioWorld Science

BioWorld Science
RSS

Tolerance to benzodiazepine hypnotics overcome with melatonin

June 6, 1997

Selective tumor targeting reported for Bexxar

June 6, 1997

Target enrollment reached in phase III trial of Interferon's Alferon N Injection

June 6, 1997

COMT inhibitor increases response to L-DOPA in patients with PD

June 6, 1997

Alpha2-antagonist effective in patients with Parkinson's disease

June 6, 1997

Clinical trials for Albuterol Spiros completed

June 6, 1997

Lilly describes potent new SERM

June 6, 1997

Potent LT biosynthesis inhibitors described by Abbott

June 6, 1997

r-metHuSCF + filgrastrim for PBPC mobilization and transplantation: a phase I/II trial

June 6, 1997

LXR refocuses Lexirin development

June 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...